Zimmer Biomet Holdings revenue and financials

ZBH · NYSE · USD

$89.68Change from previous close: −2.06%Absolute change: −$1.89

Close · October 6, 2026

In the fiscal year ended December 2025, Zimmer Biomet Holdings reported revenue of $8.23B (+7.20% year over year). Net income was $705.1M, a net margin of 8.6%.

Annual revenue · 2025: $8.23B
  1. $7.67B2016
  2. $7.8B2017
  3. $7.93B2018
  4. $7.98B2019
  5. $6.13B2020
  6. $6.83B2021
  7. $6.94B2022
  8. $7.39B2023
  9. $7.68B2024
  10. $8.23B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+7.20%
2025 vs 2024
Net income growth
−21.98%
2025 vs 2024
Net margin
8.6%
2024: 11.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue8,2327,6797,3946,9406,8276,1287,9827,9337,8037,668
Cost of revenue2,4942,1912,0842,0201,9601,8242,2532,2722,1332,382
Gross profit5,7385,4995,3194,9204,867—————
Selling, general and administrative3,2122,8762,7932,6682,626—————
Research and development459437459406436—————
Operating income1,0981,2861,27869686083.11,13833.8799821
EBIT1,4021,5941,5051,2861,222—————
EBITDA2,4952,5902,4572,2132,160—————
Interest expense293218201165208—————
Pre-tax income8311,0371,067404499—————
Income tax12613142.211253.5-96.0-226108-1,34995.0
Net income7059041,024231402-1391,132-3791,814306
Net income to common shareholders7059041,024231402—————
Basic EPS3.564.454.911.101.93-0.675.52-1.868.981.53
Diluted EPS3.554.434.881.101.91-0.675.47-1.868.901.51
Average shares (basic)198203209210209—————
Average shares (diluted)199204210210210207207204204202
Dividend per share0.960.960.960.960.96—————